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The role of envelope protein-linked N-glycans in porcine reproductive and respiratory syndrome virus (PRRSV)
infection of permissive cells was examined. N-acetylglucosamine (GlcNAc) and N-acetyllactosamine (LacNAc)
oligomer-speciﬁc lectins bound to PRRSV and blocked virus attachment, resulting in reduced viral infection.
However, addition of GlcNAc oligomers and LacNAc to cell culture together with PRRSV did not block infection.
Removal or alteration of envelope protein-linked N-glycans also did not affect virus infection, indicating that
PRRSV N-glycans are not required for virus infection. These ﬁndings show that steric hindrance of glycans on
the PRRSV envelope by lectins or, presumably, other space-ﬁlling molecules, may interfere nonspeciﬁcally with
infection by blocking protein interactions with cell surface receptors. Glycans themselves appear not to be
required for infection of permissive cells, but may have important roles in avoidance of host immunity and in
protein structure, intracellular virion growth and assembly.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Porcine reproductive and respiratory syndrome (PRRS), which is
characterized by reproductive failure in sows and respiratory distress
in growing pigs, emerged in the 1980s and soon became an economic-
ally important infectious disease worldwide. The etiologic agent,
PRRSV, was ﬁrst isolated as the type 1 European strain Lelystad virus
(LV) in the Netherlands (Wensvoort et al., 1991) and shortly after as the
type 2 North American strain VR-2332 in the USA (Benﬁeld et al.,
1992; Collins et al., 1992). Based on similar genomic organization and
transcription strategy, PRRSV, together with equine arteritis virus
(EAV), lactate dehydrogenase-elevating virus (LDV) and simian hemor-
rhagic fever virus (SHFV), belongs to the order Nidovirales, family
Arteriviridae, genus Arterivirus (Cavanagh, 1997).
PRRSV has a positive single-stranded RNA genome of approxi-
mately 15 kb and contains 10 open reading frames (ORFs). ORF1a and
ORF1b encode nonstructural proteins (nsps) responsible for virus
replication and transcription (Kroese et al., 2008; Meulenberg, 2000;
Snijder and Meulenberg, 1998). ORF2a, ORF2b, ORF5a and ORFs3–7
encode 8 structural proteins, four of which are envelope glycoproteins
(GPs), GP2a, GP3, GP4 and GP5 (Dea et al., 2000). The E protein
(encoded by ORF2b), matrix (M) protein (encoded by ORF6) and
ORF5a protein are also present on virus envelope, but are not
glycosylated (Johnson et al., 2011; Mardassi et al., 1996; Wu et al.,
2001). GP5 andM are the major envelope proteins that form disulﬁde-
bonded heterodimeric complexes and together comprise at least half
of the viral protein mass (Dea et al., 2000; Mardassi et al., 1996;
Meulenberg et al., 1995; Wissink et al., 2005). GP5 contains 3 putative
N-glycosylation sites at residues 33, 44 and 51 in VR-2332 and
2 putative N-glycosylation sites at residues 46 and 53 in LV. Lack of
the oligosaccharides linked to N44 (type 2 strains) and N46 (type
1 strains) in GP5 impairs the production of infectious progeny virus
and signiﬁcantly reduces viral infectivity (Ansari et al., 2006; Wissink
et al., 2004). Minor proteins GP2a, E, GP3 and GP4 are incorporated as
multimeric complexes in the envelope, with the glycoproteins contain-
ing conserved N-glycosylation sites in both types (Wissink et al.,
2005). Glycan additions at N184 of GP2a, N42, N50 and N131 of GP3,
andmultiple locations (N37, 84,120 and 130) of GP4 are also necessary
for infectious virus production (Das et al., 2011).
While PRRSV-linked glycans are critical structural components in
virus assembly, possibly due to proper protein folding, they are also
suggested to interact with host cells and thus are important for virus
infection. Removal of complex-type N-glycans from PRRSV reduced
infectivity in porcine macrophages (Delputte and Nauwynck, 2004). In
particular, sialic acids on GP5 bind sialoadhesin on macrophages,
mediating virus attachment and internalization (Delputte and
Nauwynck, 2004; Van Breedam et al., 2010; Van Gorp et al., 2008).
In addition to sialic acids, we recently identiﬁed some characteristic
N-glycan moieties, N-acetylglucosamine (GlcNAc) and N-acetyllac-
tosamine (LacNAc) oligomers in GP5 of type 2 PRRSV and showed
that they were accessible for speciﬁc lectin binding (Li and Murtaugh,
accepted for publication). A previous study also showed that ﬁcolin,
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speciﬁc for GlcNAc, bound and reduced PRRSV infectivity inMARC-145
cells (Keirstead et al., 2008), a simian cell line routinely used for
in vitro PRRSV propagation.
We show here that GlcNAc and LacNAc oligomer-speciﬁc lectins
bind to type 2 PRRSV and block virus attachment, resulting in reduced
viral infection. However, addition of soluble GlcNAc oligomers and
LacNAc to permissive cell cultures does not block infection. Moreover,
removal or alteration of N-glycans from PRRSV does not affect virus
infection. These observations suggest that N-glycans are not required
for efﬁcient PRRSV infection, but their binding to soluble lectins can
reduce infection via steric hindrance.
Results
GlcNAc and LacNAc oligomer-speciﬁc lectins reduce PRRSV binding
and infection of MARC-145 cells
Previously, we showed that GlcNAc and LacNAc oligomer-speciﬁc
lectins bound PRRSV. To understand how this binding would affect
virus entry and infection, PRRSV was treated with different concentra-
tions of lectins before inoculation into MARC-145 cells. Pokeweed
mitogens (PWM), a lectin speciﬁc for GlcNAc and LacNAc oligomers
(Irimura and Nicolson, 1983; Yokoyama et al., 1978), signiﬁcantly
blocked virus binding to cells in a dose-dependent manner (Fig. 1A).
Lycopersicon esculentum agglutinin (LEA) shares similar carbohydrate
speciﬁcity with PWM (Kawashima et al., 1990). Both lectins at 100 and
500 nM signiﬁcantly reduced PRRSV infection at 20 h post-infection
when compared to the “cellþ lectin” control (Fig. 1B). Pretreatment of
cells with PWM or LEA did not reduce virus infection (Fig. 1B).
Consistently, the progeny virus in culture supernatant from the ﬁrst-
cycle replication at 10 h after infection was signiﬁcantly decreased by
PWM treatment of virus compared to PWM treatment of cells (Fig. 1C).
Ten hours was chosen since PRRSV replication and virion assembly are
completed in 9 h (Pol et al., 1997). Progeny virus at 20 h post-infection
was also decreased, but the difference was not statistically signiﬁcant
(data not shown).
Wheat germ agglutinin (WGA) binds a broad range of sialic acids
and Maackia amurensis agglutinin (MAA) speciﬁcally binds α2–3-
linked sialic acids. Pretreatment of MARC-145 cells with WGA and
MAA resulted in stronger inhibition of virus infection than did lectin
treatment of virus (Fig. 1B), suggesting that these two lectins interact
with MARC-145 cells and confound the analysis of their effect on virus
infection. Dolichos biﬂorus agglutinin (DBA), which has an afﬁnity for
100 
75 
25 
0 
0 25 50 75 100 150 
PWM Concentration ( g/ml) 
R
el
at
iv
e 
P
er
ce
nt
 V
iru
s 
B
in
di
ng
 
50 
PWM LEA WGA MAA DBA Positive 
virus 120 
80 
0 R
el
at
iv
e 
pe
rc
en
t i
nf
ec
tio
n 
40 
Virus + lectin
Cell + lectin
1 5 1 5 
Lectin concentration (x 100 nM) 
1 5 1 5 1 5 1 5 1 5 1 5 1 5 1 5 0 
** 
*** 
* * * 
200 
150 
50 
0 
100 100 500 500 0 PWM Concentration (nM) 
R
el
at
iv
e 
pe
rc
en
t p
ro
ge
ny
 v
iru
s 
100 
+ Virus + Virus + Cell + Cell Virus Only 
p<0.05 p<0.05 
Fig. 1. Effect of lectins on PRRSV binding and infection of MARC-145 cells. (A) To test virus binding, PRRSV was incubated with PWM at 37 1C for 30 min. The virus–PWM
mixtures were inoculated onto MARC-145 cells at 4 1C for 30 min and processed for ﬂow cytometry. Relative percent virus binding was determined by mean ﬂuorescence
intensity (MFI). (B) To test virus infection, PRRSV was incubated with lectins and mixtures were added to MARC-145 cells as described in Materials and methods. Control cells
were pretreated with lectins prior to infection. The infected cell percentage was measured by ﬂow cytometry after 20 h incubation. (C) Progeny virus in culture supernatant
at 10 h post-infection was measured by quantitative RT-PCR. “Virusþ lectin” groups were compared to “cellþ lectin” groups using two-way ANOVA. Data represent
mean7standard errors of replicate or triplicate samples. * indicates statistical signiﬁcance at pr0.05; ** at pr0.01; *** at pr0.001.
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terminal N-acetyl-α-D-galactosaminyl residues (Etzler and Kabat,
1970), did not signiﬁcantly affect virus infection either by lectin
treatment of virus or cells.
These lectins were also tested in porcine alveolar macrophages
(PAM), the naturally permissive cells for PRRSV infection. However,
except for DBA, the lectins had a stronger inhibitory effect on virus
infection when PAM were treated with lectins than when virus was
treated with lectins prior to infection (data not shown). Thus PAM did
not serve as a good cell model for lectin inhibition experiments due to
potentially complex interactions among PAM, PRRSV and lectins.
GlcNAc oligomers and LacNAc do not affect PRRSV infection of MARC-
145 cells
The observation that GlcNAc and LacNAc oligomer-speciﬁc lectins
bound PRRSV and reduced infection suggested that these glycan
moieties on the PRRSV envelope might be involved in virus entry of
host cells. To directly test this hypothesis, MARC-145 cells were infected
in the presence of increasing concentrations of GlcNAc monomer,
dimer, trimer, tetramer, LacNAc monomer (LacNAc oligomers were not
available) or mannose to block virus attachment. Virus (106 TCID50)
was incubated with saccharide for 1 h, the mixture was added to cells
at MOI¼2.0 for 1 h, then cells were washed and cultured for 20 h.
Surprisingly, none of the tested glycan moieties affected virus infection
at concentrations from 10 mM to 5mM (Fig. 2A). Incubation of cells
with saccharide ﬁrst for 1 h followed by addition of virus for 1 h
consistently resulted in no effect or an enhancement of infection
(Fig. 2B). These results indicated that envelope protein glycans were
not directly involved in PRRSV entry and that lectin binding to virus
might interfere with virus attachment to host cells via steric hindrance.
Removal of N-glycans from PRRSV does not affect virus infection of
MARC-145 or PAM
To further investigate the role of PRRSV glycans in infection, we
examined the effect of enzymatic glycan removal on virus infectivity.
Digestion conditions were established by monitoring reactions for
molecular weight changes in GP5, the most abundant envelope
glycoprotein. The minor envelope glycoproteins, GP2a, GP3 and GP4,
were not discernible in the gel due to low abundance. In reducing SDS-
PAGE, PRRSV shows 3 major protein bands: GP5 (Fig. 3A, band 1, 25–
29 kD), M (19 kD) and N (14 kD). Intact PRRSV treatment with increas-
ing amounts of PNGase F (36 kD), which cleaves all types of N-glycans,
resulted in the disappearance of GP5 and the appearance of a new band
(Fig. 3A, band 2) between M and N. Mass spectrometric analysis
identiﬁed this new band as GP5. Deglycosylated GP5 is approximately
19 kD, similar to M, but has a lower isoelectric point (pI 8.87) thanM (pI
10.03), accounting for its appearance below M in the gel. Thus, PNGase
F treatment quantitatively removed N-glycans from PRRSV envelope
proteins. After Endo Hf treatment, which cleaves high-mannose and
hybrid-type N-glycans, the GP5 band (Fig. 3A, band 3) migrated only
2 kD lower in the gel. Thus, the complex-type N-glycans, which are
resistant to Endo Hf digestion, are the dominant glycan type and are still
present in the PRRSV envelope after Endo Hf treatment.
Although PRRSV N-glycans were differentially sensitive to PNGase F
and Endo Hf, treatment with either enzyme did not alter infection in
MARC-145 cells (Fig. 3B). In PAM, virus infection was not reduced by
PNGase F treatment of virus at 100 and 200 U/ml (Fig. 3C), concentra-
tions that removed N-glycans from GP5 (Fig. 3A). Treatment of PRRSV
with PNGase F at 400 U/ml and Endo Hf at all concentrations
signiﬁcantly reduced infection in PAM compared to the untreated
virus control (Fig. 3C). However, the inhibitory effect was not speciﬁc
to the virus, since endoglycosidase treatment of PAM before addition
of virus also signiﬁcantly reduced infection (Fig. 3C), a result consistent
with the nonspeciﬁc effect of lectin treatment observed previously.
Heat treatment of PRRSV at 37 1C for 1 h did not signiﬁcantly impair
virus infectivity (Fig. 3B and 3C). These results further indicate that N-
glycans are not required for PRRSV infection.
Alteration of the N-glycosylation pattern does not affect virus
infection
The observation that PNGase F treatment of PRRSV did not reduce
infection is in contrast to a previous report that complex-type
Fig. 2. Effect of GlcNAc and LacNAc saccharides on PRRSV infection of MARC-145 cells. (A) PRRSV was incubated with the indicated concentrations of saccharides for 1 h,
then the mixtures were added to cells at an MOI of 2.0 for 1 h. The infected cell percentage was measured by ﬂow cytometry after 20 h incubation. (B) Conﬂuent MARC-145
cells were incubated with the indicated concentrations of saccharides for 1 h. Puriﬁed PRRSV was added for 1 h. Cells were washed and incubated for 20 h. The infected cell
percentage was measured by ﬂow cytometry. The dashed line shows the percent of infected cells in wells infected with virus in the absence of added saccharides.
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N-glycans are important for PRRSV infection of PAM (Delputte and
Nauwynck, 2004). Therefore, we repeated the experiment with an
independent approach to alter viral envelope protein glycosylation
without enzymatic digestion. The viral N-glycosylation pattern was
modiﬁed by pharmacological inhibition of Golgi α-mannosidase II,
which catalyzes the ﬁrst committed step in the biosynthesis of
complex-type N-glycans, with swainsonine (SW) (Tulsiani et al.,
1982). Inhibition of the formation of complex-type N-glycans
increases the portion of high-mannose and hybrid-type N-glycans
(Tulsiani and Touster, 1983). Thus, PRRSV was propagated in MARC-
145 cells in the presence of swainsonine at 1.5 mg/ml and puriﬁed.
Endoglycosidase treatment of puriﬁed virus conﬁrmed that swain-
sonine altered glycan types on PRRSV. The virus became highly
sensitive to Endo Hf digestion, showingmultiple GP5 bands of reduced
molecular weight on SDS-PAGE while retaining complete sensitivity to
PNGase F (Fig. 4A). The identities of the new bands as GP5 glycoforms
were conﬁrmed by mass spectrometric analysis (data not shown).
Since PRRSV GP5 from cells not treated with swainsonine was
primarily resistant to Endo Hf (Fig. 3A), the increased sensitivity to
Endo Hf was due to a shift in glycan composition from Endo Hf-
resistant complex-type N-glycans to Endo Hf-sensitive high-mannose
and hybrid-type N-glycans. Although swainsonine treatment altered
the glycan pattern on PRRSV envelope proteins, there was no diff-
erence in virus growth curves at swainsonine concentrations up to
5 mg/ml (Fig. 4B). PRRSV harvested from MARC-145 cultures in the
Fig. 3. Effect of endoglycosidase digestion on PRRSV infection of MARC-145 cells
and PAM. PRRSV was treated with PNGase F or Endo Hf (each at 100, 200 and
400 U/ml) at 37 1C for 1 h. (A) SDS-PAGE of virus-enzyme mixtures. Band 1, GP5;
band 2, GP5 without N-glycans; band 3, GP5 without high-mannose or hybrid-type
N-glycans. Virus–enzyme mixtures were inoculated onto MARC-145 cells (B) or
PAM (C) at 37 1C for 1 h. After infection, cells were washed to remove enzyme and
unbound virus, and further incubated for 19 h. Control cells were pretreated with
PNGase F or Endo Hf at 37 1C for 1 h and washed extensively prior to virus infection.
Virus without enzyme treatment was treated at 37 1C for 1 h to serve as a
temperature stability control. Data represent mean7standard errors of triplicate
samples. Treatment groups were compared to the positive virus control. * indicates
statistical signiﬁcance at pr0.05; ** at pr0.01; *** at pr0.001.
Fig. 4. Effect of swainsonine on PRRSV infection of MARC-145 cells. (A) PRRSV was
propagated in MARC-145 cells with swainsonine at 1.5 mg/ml. Puriﬁed virus was
treated with PNGase F or Endo Hf as described in Fig. 3 legend and analyzed in SDS-
PAGE. Band 1, GP5; bands 2–5, GP5 without high-mannose or hybrid-type
N-glycans; band 6, GP5 without N-glycans. (B) PRRSV was cultured in MARC-145
cells with or without swainsonine as indicated for 3 days. The amount of progeny
virus in culture supernatant was measured by quantitative RT-PCR. Data represent
mean7standard errors of replicate samples. (C) PRRSV grown on MARC-145 cells
without or with 1 or 5 mg/ml swainsonine were cultured with PAM at an MOI of
0.5 or 2.0. After 10 h, the percentage of infected cells was determined by FACS as
described in Materials and methods.
J. Li, M.P. Murtaugh / Virology 477 (2015) 82–88 85
presence of 1 or 5 mg/ml swainsonine also infected PAM equivalently
to control PRRSV at multiplicities of infection (MOI) of 0.5–2.0 (Fig. 4C).
Discussion
PRRSV envelope protein glycans play important roles in virus
assembly, virus neutralization and antigenicity (Ansari et al., 2006;
Das et al., 2011; Wissink et al., 2004). In addition to sialic acids that
bind sialoadhesin (Delputte and Nauwynck, 2004), we recently
identiﬁed GlcNAc and LacNAc oligomers in GP5-linked N-glycans
and showed that lectins speciﬁc for these glycan moieties bound
PRRSV (Li and Murtaugh, accepted for publication). Therefore, we
investigated the effect of N-glycan perturbations to understand the
role of PRRSV N-glycans in permissive cell infection.
Lectins speciﬁc for GlcNAc and LacNAc oligomers, when pre-
incubated with PRRSV, reduced virus binding and infection of MARC-
145 cells. However, GlcNAc and LacNAc oligomers themselves did not
compete with virus to block infection. Thus, the inhibitory effect of
these speciﬁc lectins appeared to be due to a nonspeciﬁc mechanism
such as steric hindrance. Consistent with this observation, removal or
alteration of envelope glycoprotein N-glycans did not alter infection,
further demonstrating that the presence of glycans is not required for
PRRSV infection.
This conclusion is in contrast to previous reports that GP5-linked
sialic acids bind sialoadhesin on PAM to mediate virus attachment and
internalization (Delputte and Nauwynck, 2004; Van Breedam et al.,
2010). It was shown that lectins speciﬁc for sialic acids reduced type I
PRRSV infection in PAM and had no effect when PAM were pre-
incubated with lectins prior to infection (Delputte and Nauwynck,
2004). However, we found that pre-incubation of PAM with lectins
speciﬁc for sialic acids, GlcNAc and LacNAc oligomers inhibited type
2 PRRSV infection. The same result was observed when sialic acid-
speciﬁc lectins were tested in MARC-145 cells. A speciﬁc binding
interaction between cells and lectins was not surprising since terminal
sialic acids, GlcNAc and LacNAc oligomers are widely distributed in
tissues and cells (Varki et al., 2009). In particular, the essential PRRSV
receptor CD163, which exists in both PAM and MARC-145 cells, has
6 or 7 predicted N-glycosylation sites in monkey (GenBank ID:
AEF30542.1) and pig (GenBank ID: ABV80230.1), respectively. Thus
lectin binding to CD163-linked glycans directly or to glycoconjugates in
the local vicinity could sterically hinder PRRSV interaction with CD163.
We and others previously identiﬁed terminal sialic acids in GP5-
linked N-glycan structures and showed that a sialic acid-speciﬁc lectin
bound to PRRSV (Van Breedam et al., 2010; Li and Murtaugh, accepted
for publication), and sialoadhesin, a cellular sialic acid receptor, was
previously identiﬁed as the PRRSV receptor on macrophages
(Nauwynck et al., 1999; Vanderheijden et al., 2003; Delputte and
Nauwynck, 2004; Delputte et al., 2007). More recent studies show that
CD163 is the PRRSV receptor and that the absence of sialoadhesin on
porcine macrophages has no effect on PRRSV infection in vivo (Calvert
et al., 2007; Prather et al. 2013). While sialoadhesin likely binds sialic
acid residues on PRRSV envelope proteins, an interaction of sialic acid
with sialoadhesin may not be relevant for PRRSV infection and growth
on simian cells since sialoadhesin is not expressed in MARC-145 cells
(Van Gorp et al., 2008; Wang et al., 2011; Welch and Calvert, 2010). It
is unlikely that the infection process is different for type 1 and type
2 PRRSV; both genotypes grow on porcine macrophages and can be
adapted to grow on simian MA-104 (also known as CL2621) cells and
its subclone, MARC-145 (Collins et al., 1992; Geldhof et al., 2013; Van
Breedam et al., 2010). Also, morphogenetic comparison of type 1 and
type 2 PRRSV showed no differences that would suggest different
mechanisms of infection (Pol et al., 1997).
In an experiment to evaluate how sialic acids would compete with
PRRSV for binding to sialoadhesin on PAM, a low molecular weight
trisaccharide, sialyllactose (634 Dalton), reduced PRRSV infection by
20% at a concentration of 1 mM, whereas high molecular weight sialic
acid-containing glycoproteins (50–66 kD) reduced infection by 53% at
0.5 mM and 77% at 2 mM (Delputte and Nauwynck, 2004). The
increased inhibitory efﬁcacy of space-ﬁlling glycoproteins compared to
small molecules suggests that the inhibitory effect was due to steric
hindrance rather than competing for sialoadhesin receptor binding.
A remarkable observation in our experiments was that removal or
alteration of the PRRSV Endo Hf-resistant complex-type N-glycans
did not affect infection. It was previously shown that PNGase F
treatment of type 1 PRRSV reduced infection in PAM by 71%, whereas
treatment of PAM had no effect (Delputte and Nauwynck, 2004).
However, our results showed that PAM treatment with either PNGase
F or Endo Hf signiﬁcantly reduced type 2 PRRSV infection equiva-
lently to the reduction caused by endoglycosidase treatment of the
virus. This observation is consistent with modiﬁcation of glycan
moieties on cell surface membrane proteins such as CD163, and
emphasizes the need to evaluate non-enzymatic methods of viral
glycan modiﬁcation. Inhibition of terminal glycan maturation in the
Golgi, which occurs before viral assembly, also did not alter viral
infection. When the complex N-glycan biosynthesis pathway was
blocked by swainsonine, there was no effect on virus infection,
demonstrating that PRRSV complex N-glycans are not important for
infection. Alteration of the N-glycosylation pattern in PRRSV envelope
proteins did not affect protein folding or virus assembly since the
growth curve was not affected.
A variety of genetic ablation experiments have been performed to
examine the role of envelope protein N-linked glycosylation in
PRRSV biology. Lack of glycans linked to N184 of GP2a, N42, N50
and N131 of GP3, multiple locations (N37, 84, 120 and 130) of GP4,
and N44/46 of GP5 is lethal for infectious PRRSV production (Ansari
et al., 2006; Das et al., 2011; Wissink et al., 2004), suggesting glycans
in these sites are important for proper protein folding and stability,
and thus for virus assembly. A multimeric structure containing GP2a,
E, GP3 and GP4 is required for PRRSV infectivity, and GP2a and GP4
are important for the interaction of PRRSV with CD163, its receptor
on permissive cells (Calvert et al., 2007; Das et al., 2010; Wissink
et al., 2005). The importance of minor envelope protein glycosylation
for viral infectivity, however, is not clear. In one study, mutations
in the two predicted GP2a sites had no effect on viral infectivity
(Wissink et al., 2004), but in another, viral interaction with CD163
was reduced, although single mutations in either site had no effect
(Das et al., 2011). Overall, it can be concluded that envelope protein
glycosylation plays important roles in PRRSV envelope glycoprotein
stability, virion assembly and maturation, but the evidence that
envelope protein glycans play a direct role in infection of permissive
cells is not compelling.
In conclusion, steric hindrance of glycans on the PRRSV virion by
lectins or, presumably, other space-ﬁlling molecules may interfere
nonspeciﬁcally with infection by blocking protein interactions with
cell surface receptors. Glycans themselves appear not to be required
for infection of permissive cells, but may have important roles in
avoidance of host immunity and in intracellular growth and assem-
bly of virions.
Materials and methods
Virus and cells
The type 2 prototype PRRSV, ATCC VR-2332, GenBank ID PRU87392
(American Type Culture Collection, Manassas VA) (Benﬁeld et al., 1992;
Nelsen et al., 1999), was propagated in MARC-145 cells (Kim et al.,
1993) using MEM (Mediatech, Herndon VA) containing 10% FBS
(Mediatech), 1 mg/ml sodium bicarbonate (Sigma-Aldrich, St. Louis
MO), 1% (v/v) 100 nonessential amino acids (Mediatech), 10 mM
HEPES solution (Mediatech) and 20 mg/ml gentamicin (Invitrogen,
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Carlsbad California) at 37 1C in a 5% CO2 incubator. After 2 days of
infection, virus was collected from culture supernatant, clariﬁed by
centrifugation, titered on MARC-145 cells and porcine alveolar macro-
phages (PAM), and stored in aliquots at 80 1C.
Porcine alveolar macrophages (PAM) were harvested by lung
lavage of 4 to 6-week old pigs as previously described (Lin et al.,
1994). Three to four 300-ml washings were centrifuged at 500g and
resuspended at 107 cells/ml in 90% FBS with 10% (v/v) dimethyl
sulfoxide (DMSO, Fisher Scientiﬁc, Pittsburgh PA) for cryopreservation
in liquid nitrogen. Prior to use, PAMs were thawed in a 37 1C water
bath, washed and maintained in RPMI 1640 (Invitrogen) containing
5% FBS, 1% (v/v) sodium pyruvate (Mediatech), 1% (v/v) 100
nonessential amino acids, 10 mM HEPES solution and 20 mg/ml
gentamicin at 37 1C in 5% CO2.
Virus puriﬁcation
VR-2332 was propagated in MARC-145 cells with or without
swainsonine for two days. Debris was removed by centrifugation at
17,000g for 1 h, and supernatant was mixed with 10% polyethylene
glycol-8000 (Fisher Scientiﬁc, Fair Lawn NJ) at 4 1C overnight. Virus
was pelleted at 22,000g for 2 h, resuspended in Tris-buffered saline
(TBS), and pelleted twice through a 0.5 M sucrose (Fisher Scientiﬁc)
cushion at 110,000g for 3 h. The ﬁnal pellet was resuspended in 20%
iodixanol (Sigma) in TBS and banded twice in a self-generating
gradient by ultracentrifugation at 250,000g for 9 h. The puriﬁed
virus band was removed with a sterile needle and stored in aliquots
at 80 1C.
Endoglycosidase digestion and SDS-PAGE
In non-reducing conditions, 2 mg of puriﬁed PRRSV was incubated
with 100, 200 or 400 units of peptide-N-glycosidase F (PNGase F,
New England Biolabs, Ipswich, MA) in 50 mM sodium phosphate
solution, pH 7.5, or endoglycosidase Hf (Endo Hf, New England
Biolabs) in 50 mM sodium citrate solution, pH 5.5, at 37 1C for 1 h.
The mixtures of virus and enzyme were added to gel loading buffer
with 5% β-mercaptoethanol, boiled for 10 min and electrophoresed
in 4–20% Mini-PROTEAN TGX gradient gels (Bio-Rad Laboratories,
Hercules CA). CandyCane Glycoprotein Molecular Weight Standards
(Invitrogen) were used to estimate protein size and protein bands
were visualized with Ruby Protein Gel Stain (Invitrogen). Finally,
proteins were analyzed in EpiChemi3 Darkroom (UVP, Upland CA)
using software LabWorks 4.5 (UVP).
Inhibition of PRRSV binding and infection
Pokeweed mitogen (PWM), Lycopersicon esculentum agglutinin
(LEA), wheat germ agglutinin (WGA), Maackia amurensis agglutinin
(MAA) and Dolichos biﬂorus agglutinin (DBA) were purchased from
Sigma. For virus attachment analysis, PRRSV was incubated with
increasing concentrations of PWM in medium at 37 1C for 30 min.
The virus–PWM mixtures were cooled and added to pre-cooled
MARC-145 cells at an MOI of 1.0 (5105 TCID50 per well of a
12-well plate) at 4 1C for 30 min. MOI was calculated using TCID50
values determined on MARC-145 cells. For virus infection analysis,
PRRSV was incubated with 100 or 500 nM lectin at 37 1C for 1 h.
MARC-145 cells were inoculated with the virus–lectin mixture at an
MOI of 1.0 at 37 1C for 1 h, washed to remove unbound virus, and
further incubated for 19 h. Cells pretreated with lectin prior to virus
infection were used to control for a lectin effect on cells. Virus
without lectin treatment served as a positive control for infection.
GlcNAc monomer, LacNAc monomer and mannose were purchased
from Sigma. GlcNAc dimer (chitobiose), trimer (chitotriose) and
tetramer (chitotetraose) were purchased from Northstar BioProducts,
East Falmouth, MA. MARC-145 cells were infected with MOI 2.0 PRRSV
in the presence of various concentrations of glycans at 37 1C for 1 h.
After washing, cells were further incubated for 19 h.
PRRSV was treated with various concentrations of PNGase F or
Endo Hf at 37 1C for 1 h. Mixtures were inoculated into MARC-145
cells or PAM at an MOI of 2.0 at 37 1C for 1 h. After washing, cells
were further incubated for 19 h. To control for an enzyme effect on
cells, cells were pretreated with PNGase F or Endo Hf at 37 1C for
1 h and washed extensively prior to virus infection. Virus without
enzyme treatment was incubated at 37 1C for 1 h to serve as a
temperature stability control.
To change the N-glycosylation pattern of PRRSV, MARC-145 cells
were pre-cultured with 1 or 5 mg/ml of swainsonine at 37 1C for 1 h.
After removing the medium, cells were infected with PRRSV (MOI
0.2) in the presence of swainsonine at 37 1C for 1 h. Cells were then
washed and further incubated with swainsonine at the same con-
centration until virus was harvested.
Flow cytometry
For virus binding analysis, after washing with PBS three times,
MARC-145 cells were treated with 1 mM EDTA (Invitrogen) for cell
dissociation. For virus infection analysis, MARC-145 cells were treated
with 0.25% trypsin-EDTA (Invitrogen) at 37 1C for 5 min. Cells then
were collected, ﬁxed and permeabilized with BD Cytoﬁx/Cytoperm
solution (Becton-Dickinson Biosciences, San Jose CA) at 4 1C for
20 min, washed with 1:10 diluted Perm/Wash buffer (BD Biosciences),
and incubated with ﬂuorescein isothiocyanate (FITC)-conjugated anti-
nucleocapsid monoclonal antibody SR30-F (Rural Technologies,
Brookings SD) at 4 1C for 30 min to detect PRRSV.
PAM were re-suspended by ﬂushing and stained with anti-
SWC3 (AbD Serotec, Raleigh NC) followed by APC-conjugated anti-
mouse IgG (BioLegend, San Diego CA) to enumerate total macro-
phages. Cells were then ﬁxed and permeabilized as described
above, then stained with ﬂuorescein-conjugated SR30-F to detect
virally-infected cells. Cells without virus infection were used as a
negative control.
Fixed and stained cells were washed and ten thousand cells per
sample were analyzed with a BD FACSCanto ﬂow cytometer. Data
were analyzed with FlowJo software (Tree Star, Ashland OR). The
mean ﬂuorescence intensity (MFI) was used to measure the
amount of virus bound to cells. The infected cell percentage was
used to measure the level of virus infection.
PRRSV quantitative reverse transcriptase (RT)-PCR
Total RNA isolation was performed using a Viral RNA Mini Kit
following the manufacturer's protocol (Qiagen, Valencia CA). RNA
was eluted in 50 ml water and 10 ml was used to prepare cDNA
using a High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City CA). Quantitative real time PCR was carried
out with 5 ml of 1:10 diluted cDNA, 10 ml of PerfeCta SYBR Green
Fast Mix (Quanta Biosciences, Gaithersburg MD), and 5 ml of 1 mM
primers with forward primer GATAACCACGCATTTGTCGTC, and
reverse primer TGCCGTTGTTATTTGGCATA. To quantify viral RNA
copies, RNA extracted from a titered VR-2332 stock was used as
standards. The ﬁnal results were expressed as RNA copies/ml
according to the standard curve.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.0
(GraphPad Software, San Diego CA). Data were analyzed either by
one-way ANOVA with Tukey's multiple comparison test or two-
way ANOVA with Bonferroni post-test. A p-value o0.05 was
considered statistically signiﬁcant.
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